Authors:
Acs, G
Lawton, TJ
Rebbeck, TR
LiVolsi, VA
Zhang, PJ
Citation: G. Acs et al., Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications, AM J CLIN P, 115(1), 2001, pp. 85-98
Authors:
Fisher, MJ
Virmani, AK
Wu, L
Aplenc, R
Harper, JC
Powell, SM
Rebbeck, TR
Sidransky, D
Gazdar, AF
El-Deiry, WS
Citation: Mj. Fisher et al., Nucleotide substitution in the ectodomain of TRAIL receptor DR4 is associated with lung cancer and head and neck cancer, CLIN CANC R, 7(6), 2001, pp. 1688-1697
Authors:
Kanetsky, PA
Holmes, R
Walker, A
Najarian, D
Swoyer, J
Guerry, D
Halpern, A
Rebbeck, TR
Citation: Pa. Kanetsky et al., Interaction of glutathione S-transferase M1 and T1 genotypes and malignantmelanoma, CANC EPID B, 10(5), 2001, pp. 509-513
Authors:
Carlini, EJ
Raftogianis, RB
Wood, TC
Jin, F
Zheng, W
Rebbeck, TR
Weinshilboum, RM
Citation: Ej. Carlini et al., Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects, PHARMACOGEN, 11(1), 2001, pp. 57-68
Authors:
Turner, BC
Krajewski, S
Krajewska, M
Takayama, S
Gumbs, AA
Carter, D
Rebbeck, TR
Haffty, BG
Reed, JC
Citation: Bc. Turner et al., BAG-1: A novel biomarker predicting long-term survival in early-stage breast cancer, J CL ONCOL, 19(4), 2001, pp. 992-1000
Authors:
Rebbeck, TR
Wang, YT
Kantoff, PW
Krithivas, K
Neuhausen, SL
Godwin, AK
Daly, MB
Narod, SA
Brunet, JS
Vesprini, D
Garber, JE
Lynch, HT
Weber, BL
Brown, M
Citation: Tr. Rebbeck et al., Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history, CANCER RES, 61(14), 2001, pp. 5420-5424
Authors:
Lovett, BD
Strumberg, D
Blair, IA
Pang, SK
Burden, DA
Megonigal, MD
Rappaport, EF
Rebbeck, TR
Osheroff, N
Pommier, YG
Felix, CA
Citation: Bd. Lovett et al., Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associated MLL translocation breakpoints, BIOCHEM, 40(5), 2001, pp. 1159-1170
Citation: Tr. Rebbeck, More about: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4, J NAT CANC, 92(1), 2000, pp. 76-76
Authors:
Kelada, SN
Kardia, SLR
Walker, AH
Wein, AJ
Malkowicz, SB
Rebbeck, TR
Citation: Sn. Kelada et al., The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: Genotype-environment interactions with smoking, CANC EPID B, 9(12), 2000, pp. 1329-1334
Citation: A. Eisen et al., Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer, J CL ONCOL, 18(9), 2000, pp. 1980-1995
Authors:
Amirimani, B
Walker, AH
Weber, BL
Rebbeck, TR
Citation: B. Amirimani et al., Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 - Response, J NAT CANC, 91(18), 1999, pp. 1588-1590
Authors:
Rebbeck, TR
Levin, AM
Eisen, A
Snyder, C
Watson, P
Cannon-Albright, L
Isaacs, C
Olopade, O
Garber, JE
Godwin, AK
Daly, MB
Narod, SA
Neuhausen, SL
Lynch, HT
Weber, BL
Citation: Tr. Rebbeck et al., Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers, J NAT CANC, 91(17), 1999, pp. 1475-1479
Authors:
Rebbeck, TR
Walker, AH
Jaffe, JM
White, DL
Wein, AJ
Malkowicz, SB
Citation: Tr. Rebbeck et al., Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer, CANC EPID B, 8(4), 1999, pp. 283-287
Authors:
Walker, AH
Najarian, D
White, DL
Jaffe, JM
Kanetsky, PA
Rebbeck, TR
Citation: Ah. Walker et al., Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays, ENVIR H PER, 107(7), 1999, pp. 517-520
Authors:
Loh, E
Rebbeck, TR
Mahoney, PD
DeNofrio, D
Swain, JL
Holmes, EW
Citation: E. Loh et al., Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure, CIRCULATION, 99(11), 1999, pp. 1422-1425